Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 8.14% | 50 K | 74.10% | 4.75% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7.69% | 15 K | 77.85% | 4.85% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7.23% | 134 K | 79.81% | 4.63% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6.32% | 2 M | 89.20% | 4.55% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
6.03% | 10.96 M | 82.34% | 4.25% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.90% | 0 | 86.37% | 4.45% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.83% | 0 | 89.56% | 4.70% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.80% | 2.09 M | 87.83% | 4.40% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.75% | 690 K | 91.27% | 4.88% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.74% | 26 K | 90.47% | 3.20% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.74% | 263 K | 90.28% | 4.63% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.73% | 400 K | 90.89% | 4.75% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.71% | 4.54 M | 92.14% | 4.85% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.70% | 13.99 M | 97.63% | 5.50% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.61% | 3.46 M | 87.44% | 4.05% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.59% | 2.13 M | 97.88% | 5.40% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.56% | 0 | 99.75% | 3.60% | 2025-05-14 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.55% | 261 K | 100.53% | 5.60% | 2055-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.32% | 0 | 92.84% | 4.30% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.26% | 1.86 M | 100.82% | 5.35% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.17% | 0 | 95.54% | 4.50% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.09% | 1.35 M | 96.43% | 4.55% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.98% | 7.45 M | 101.47% | 5.20% | 2035-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.95% | 941 K | 100.64% | 5.05% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.65% | 25.14 M | 94.45% | 3.20% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.59% | 2.04 M | 101.68% | 4.95% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.54% | 6.21 M | 101.37% | 4.88% | 2030-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.43% | 1.07 M | 101.25% | 4.80% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.42% | 0 | 98.69% | 3.20% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.35% | 7.89 M | 99.69% | 4.25% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.33% | 3.59 M | 97.87% | 2.95% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.32% | 9.78 M | 100.87% | 4.65% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.22% | 25.97 M | 101.05% | 4.80% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.03% | 0 | 95.56% | 2.63% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS | |
XXS162262122ALLERGAN FNDG 17/29 | 3.97% | 0 | 93.39% | 2.13% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
3.86% | 0 | 96.53% | 2.95% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
3.19% | 0 | 89.37% | 1.25% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.90% | 0 | 121.31% | 4.25% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.89% | 0 | 97.14% | 2.13% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.88% | 0 | 126.76% | 4.75% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.83% | 0 | 128.71% | 4.85% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.74% | 0 | 99.61% | 2.63% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.70% | 0 | 98.08% | 2.13% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.61% | 0 | 95.40% | 0.75% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.35% | 0 | 123.74% | 4.55% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
— | — | — | 4.40% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |